Changing the inhibitory specificity and function of the proteinase inhibitor eglin c by site-directed mutagenesis: functional and structural investigation.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Biochemistry

• Publication date

  1992-09-22

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/BI00152A011PMID 1390662
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Natural protein proteinase inhibitors and their interaction with proteinases.

  1992cited by this paper
• Replacement of P1 Leu18 by Glu18 in the reactive site of turkey ovomucoid third domain converts it into a strong inhibitor of Glu-specific Streptomyces griseus proteinase (GluSGP).

  1991cited by this paper
• Refined crystal structures of subtilisin novo in complex with wild-type and two mutant eglins. Comparison with other serine proteinase inhibitor complexes.

  1991cited by this paper
• Inhibition of subtilisin BPN' by reaction site P1 mutants of Streptomyces subtilisin inhibitor.

  1991cited by this paper
• An evaluation of computational strategies for use in the determination of protein structure from distance constraints obtained by nuclear magnetic resonance.

  1991cited by this paper
• Recombinant chymotrypsin inhibitor 2: expression, kinetic analysis of inhibition with alpha-chymotrypsin and wild-type and mutant subtilisin BPN', and protein engineering to investigate inhibitory specificity and mechanism.

  1990cited by this paper
• Sequence-specific 1H NMR assignments and secondary structure of eglin c.

  1990cited by this paper
• Human leukocyte and porcine pancreatic elastase: X-ray crystal structures, mechanism, substrate specificity, and mechanism-based inhibitors.

  1989cited by this paper
• The refined 1.9 A crystal structure of human alpha‐thrombin: interaction with D‐Phe‐Pro‐Arg chloromethylketone and significance of the Tyr‐Pro‐Pro‐Trp insertion segment.

  1989cited by this paper
• A heteronuclear three-dimensional NMR experiment for measurements of small heteronuclear coupling constants in biological macromolecules

  1989cited by this paper
• Novel inhibitors of human leukocyte elastase and cathepsin G. Sequence variants of squash seed protease inhibitor with altered protease selectivity.

  1989cited by this paper
• Accurate measurements of long-range heteronuclear coupling constants from homonuclear 2D NMR spectra of isotope-enriched proteins

  1989cited by this paper
• Structural comparison of two serine proteinase-protein inhibitor complexes: eglin-c-subtilisin Carlsberg and CI-2-subtilisin Novo.

  1988cited by this paper
• RIBBON: a stereo cartoon drawing program for proteins

  1988cited by this paper
• Iterative schemes for bilinear operators; application to spin decoupling

  1988cited by this paper
• Kinetic studies on the interaction of eglin c with human leukocyte elastase and cathepsin G.

  1987cited by this paper
• Ovomucoid third domains from 100 avian species: isolation, sequences, and hypervariability of enzyme-inhibitor contact residues.

  1987cited by this paper
• The high-resolution X-ray crystal structure of the complex formed between subtilisin Carlsberg and eglin c, an elastase inhibitor from the leech Hirudo medicinalis Structural analysis, subtilisin structure and interface geometry

  1987cited by this paper
• Stereospecific assignments of side-chain protons and characterization of torsion angles in Eglin c.

  1987cited by this paper
• The high-resolution X-ray crystal structure of the complex formed between subtilisin Carlsberg and eglin c, an elastase inhibitor from the leech Hirudo medicinalis. Structural analysis, subtilisin structure and interface geometry.

  1987cited by this paper
• Refined 1.2 A crystal structure of the complex formed between subtilisin Carlsberg and the inhibitor eglin c. Molecular structure of eglin and its detailed interaction with subtilisin.

  1986cited by this paper
• Kinetics of the inhibition of thrombin by hirudin.

  1986cited by this paper
• X‐ray crystal structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor.

  1986cited by this paper
• Altered specificities of genetically engineered alpha 1 antitrypsin variants.

  1986cited by this paper
• Altered specificities of genetically engineered α1 antitrypsin variants

  1986cited by this paper
• Crystal and molecular structure of the inhibitor eglin from leeches in complex with subtilisin Carlsberg

  1985cited by this paper
• A large fragment approach to DNA synthesis: total synthesis of a gene for the protease inhibitor eglin c from the leech Hirudo medicinalis and its expression in E. coli.

  1984cited by this paper
• Fast atom bombardment (FAB) mass spectrometry: a mass spectral investigation of some of the insulins.

  1984cited by this paper
• Different base/base mismatches are corrected with different efficiencies by the methyl-directed DNA mismatch-repair system of E. coli.

  1984cited by this paper
• Evolution of proteolytic enzymes.

  1984cited by this paper
• Hydrogen bond length and proton NMR chemical shifts in proteins

  1983cited by this paper
• New M13 vectors for cloning.

  1983cited by this paper
• Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder.

  1983cited by this paper
• Protein conformation and proton nuclear-magnetic-resonance chemical shifts.

  1983cited by this paper
• Oligonucleotide-directed mutagenesis of DNA fragments cloned into M13 vectors.

  1983cited by this paper
• [2] New M13 vectors for cloning

  1983cited by this paper
• Coherence transfer by isotropic mixing: Application to proton correlation spectroscopy

  1983cited by this paper
• Indirect detection of mercury-199 NMR: adducts of ethylmercury phosphate with amino acids and ribonuclease

  1982cited by this paper
• Sequential resonance assignments in protein 1H nuclear magnetic resonance spectra. Basic pancreatic trypsin inhibitor.

  1982cited by this paper
• Two-dimensional chemical exchange and cross-relaxation spectroscopy of coupled nuclear spins

  1981cited by this paper
• A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules.

  1980cited by this paper
• Structure of the elastase-cathepsin G inhibitor of the leech Hirudo medicinalis.

  1980cited by this paper
• Protein inhibitors of proteinases.

  1980cited by this paper
• Crystal structure of the complex of subtilisin BPN' with its protein inhibitor Streptomyces subtilisin inhibitor. The structure at 4.3 Angstroms resolution.

  1979cited by this paper
• Investigation of exchange processes by two‐dimensional NMR spectroscopy

  1979cited by this paper
• 1H‐nmr parameters of the common amino acid residues measured in aqueous solutions of the linear tetrapeptides H‐Gly‐Gly‐X‐L‐Ala‐OH

  1979cited by this paper
• Functional expression of cloned yeast DNA in Escherichia coli: specific complementation of argininosuccinate lyase (argH) mutations.

  1978cited by this paper
• A graphics model building and refinement system for macromolecules

  1978cited by this paper
• Isolation and characterisation of a low molecular weight inhibitor (of chymotrypsin and human granulocytic elastase and cathepsin G) from leeches.

  1977cited by this paper
• DNA sequencing with chain-terminating inhibitors.

  1977cited by this paper
• Preparation and characterization of the active derivative bovine trypsin-kallikrein inhibitor (Kunitz) with the reactive site lysine-15 -- alanine-16 hydrolyzed.

  1976cited by this paper
• Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene.

  1975cited by this paper
• Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. II. Crystallographic refinement at 1.9 A resolution.

  1974cited by this paper
• 254. The solution conformation of cyclo-glycyl-L-prolyl-glycyl-glycyl-L-prolyl-glycyl. Communication 22 (preliminary) on homodetic cyclic polypeptides.

  1972cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• [2] Titration of trypsin, plasmin, and thrombin with p-nitrophenyl p′-guanidinobenzoate HCl☆

  1970cited by this paper
• On the size of the active site in proteases. I. Papain.

  1967cited by this paper

• The High‐Affinity Chymotrypsin Inhibitor Eglin C Poorly Inhibits Human Chymotrypsin‐Like Protease: Gln192 and Lys218 Are Key Determinants

  2024cites this paper
• An intermolecular salt bridge linking substrate binding and P1 substrate specificity switch of arterivirus 3C-like proteases

  2022cites this paper
• Loss of second and sixth conserved cysteine residues from trypsin inhibitor-like cysteine-rich domain-type protease inhibitors in Bombyx mori may induce activity against microbial proteases.

  2016cites this paper
• Conception, synthèse et caractérisation biologique d'inhibiteurs peptidomimétiques de la matriptase

  2016cites this paper
• Long-range Electrostatic Complementarity Governs Substrate Recognition by Human Chymotrypsin C, a Key Regulator of Digestive Enzyme Activation*

  2013cites this paper
• STRUCTURAL ASPECTS OF STRONG INHIBITION AND ROLE OF SCAFFOLD FOR SERINE PROTEASE INHIBITORS

  2013cites this paper
• Mastering the Canonical Loop of Serine Protease Inhibitors: Enhancing Potency by Optimising the Internal Hydrogen Bond Network

  2011cites this paper
• Phage display as a powerful tool to engineer protease inhibitors.

  2010cites this paper
• Proteases as anti-cancer targets--molecular and biological basis for development of inhibitor-like drugs against cancer.

  2009cites this paper
• Design of peptide inhibitors for furin based on the C‐terminal fragment of histone H1.2

  2008cites this paper
• Sequence-specific dynamics modulate recognition specificity in WW domains

  2007cites this paper
• Rigidification of a flexible protease inhibitor variant upon binding to trypsin.

  2007cites this paper
• Interaction of Subtilisin BPN′ and Recombinant Fungal Protease Inhibitor F from Silkworm with Substituted P1 Site Residues

  2006cites this paper
• A Kunitz-type glycosylated elastase inhibitor with one disulfide bridge.

  2006cites this paper
• A Kunitz-Type Glycosylated Elastase Inhibitor with One Disulfide Bridge

  2006cites this paper
• Despite having a common P1 Leu, eglin C inhibits alpha-lytic proteinase a million-fold more strongly than does turkey ovomucoid third domain.

  2006cites this paper
• Inhibition of human matriptase by eglin c variants

  2006cites this paper
• Structural and functional study of an Anemonia elastase inhibitor, a "nonclassical" Kazal-type inhibitor from Anemonia sulcata.

  2005cites this paper
• Plant serine proteinase inhibitors.

  2005cites this paper
• Improvement of the specificity of dipetarudin by site directed mutagenesis

  2005cites this paper
• Role of the intramolecular hydrogen bond network in the inhibitory power of chymotrypsin inhibitor 2.

  2005cites this paper
• Rational redesign of inhibitors of furin/kexin processing proteases by electrostatic mutations.

  2004cites this paper
• Identification of a residue critical for maintaining the functional conformation of BPTI.

  2003cites this paper
• Review Canonical protein inhibitors of serine proteases

  2003cites this paper
• Inhibitory specificity change of the ovomucoid third domain of the silver pheasant upon introduction of an engineered Cys14-Cys39 bond.

  2003cites this paper
• Canonical protein inhibitors of serine proteases

  2003cites this paper
• A clogged gutter mechanism for protease inhibitors

  2002cites this paper
• Amide proton temperature coefficients as hydrogen bond indicators in proteins

  2001cites this paper
• Novel Approaches to the Treatment of Hepatitis C Virus Infection

  2000cites this paper
• Substitutions at the P(1) position in BPTI strongly affect the association energy with serine proteinases.

  2000cites this paper
• Deciphering the role of the electrostatic interactions involving Gly70 in eglin C by total chemical protein synthesis.

  2000cites this paper
• Probing intermolecular backbone H-bonding in serine proteinase-protein inhibitor complexes.

  1999cites this paper
• Solution structure and dynamics of a serpin reactive site loop using interleukin 1beta as a presentation scaffold.

  1999cites this paper
• Protein inhibitors of serine proteinases.

  1999cites this paper
• Solution structure and dynamics of a serpin reactive site loop using interleukin 1β as a presentation scaffold

  1999cites this paper
• Selection of human elastase inhibitors from a conformationally constrained combinatorial peptide library.

  1999cites this paper
• Molecular flexibility profiling using NMR spectroscopy.

  1999cites this paper
• Design of selective eglin inhibitors of HCV NS3 proteinase.

  1998cites this paper
• The role of threonine in the P2 position of Bowman-Birk proteinase inhibitors: studies on P2 variation in cyclic peptides encompassing the reactive site loop.

  1998influential citation
• Intrinsic Specificity of the Reactive Site Loop of α1-Antitrypsin, α1-Antichymotrypsin, Antithrombin III, and Protease Nexin I*

  1997cites this paper
• Intrinsic specificity of the reactive site loop of alpha1-antitrypsin, alpha1-antichymotrypsin, antithrombin III, and protease nexin I.

  1997cites this paper
• Complete amino acid sequences of two trypsin inhibitors from buckwheat seed.

  1996cites this paper
• Changing the inhibitory specificity and function of Cucurbita maxima trypsin inhibitor-V by site-directed mutagenesis.

  1995cites this paper
• Site-directed mutagenesis studies of the high-affinity streptavidin-biotin complex: contributions of tryptophan residues 79, 108, and 120.

  1995cites this paper
• Structures of a series of 6-kDa trypsin inhibitors isolated from the stigma of Nicotiana alata.

  1995cites this paper
• Combined use of 13C chemical shift and 1Hα−13Cα heteronuclear NOE data in monitoring a protein NMR structure refinement

  1995cites this paper
• Proteinase inhibitors from the European medicinal leech Hirudo medicinalis: structural, functional and biomedical aspects.

  1995cites this paper
• Frequency spectrum of NH bonds in eglin c from spectral density mapping at multiple fields.

  1995cites this paper
• 1H NMR solution structure of an active monomeric interleukin-8.

  1995cites this paper
• 8 – Reversible Inhibitors of Serine Proteinases: Naturally Occurring Miniproteins, Semisynthetic Variants, Recombinant Homologs, and Synthetic Peptides

  1995cites this paper
• Combined use of 13C chemical shift and 1H alpha-13C alpha heteronuclear NOE data in monitoring a protein NMR structure refinement.

  1995cites this paper
• Inhibitors of human leukocyte elastase.

  1994cites this paper
• Contribution of residues in the reactive site loop of chymotrypsin inhibitor 2 to protein stability and activity.

  1994cites this paper
• Expression and kinetic characterization of barley chymotrypsin inhibitors 1a and 1b.

  1994cites this paper
• Primary structure and specificity of the major serine proteinase inhibitor of amaranth (Amaranthus caudatus L.) seeds.

  1994cites this paper
• Secretory production of chicken ovomucoid domain 3 by Escherichia coli and alteration of inhibitory specificity toward proteases by substitution of the P1 site residue.

  1994cites this paper
• Secretory production of chicken ovomucoid domain 3 by Escherichia coli and alteration of inhibitory specificity toward proteases by substitution of the P1 site residue.

  1994cites this paper
• 1H NMR studies of interleukin 8 analogs: characterization of the domains essential for function.

  1994cites this paper
• Study of Protein Dynamics by NMR

  1993cites this paper
• Context dependence of protein secondary structure formation: the three-dimensional structure and stability of a hybrid between chymotrypsin inhibitor 2 and helix E from subtilisin Carlsberg.

  1993cites this paper
• Chemical synthesis, molecular cloning, overexpression, and site-directed mutagenesis of the gene coding for pumpkin (Curcubita maxima) trypsin inhibitor CMTI-V.

  1993cites this paper